[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fXcFZLC6-s4v58RhTr2MWQt3iBcNF-EXU0wFG6IJ3zFE":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":58,"rows":65},"Centre Hospitalier Intercommunal Creteil",[4],127,false,32,12,77514,7,108,[14,17,19,21,23,26,28,30],{"name":15,"count":16},"Sickle Cell Disease",4,{"name":18,"count":16},"Bronchopulmonary Dysplasia",{"name":20,"count":16},"Infertility",{"name":22,"count":16},"Covid19",{"name":24,"count":25},"Endometriosis",3,{"name":27,"count":25},"Pre-Eclampsia",{"name":29,"count":25},"Macular Degeneration",{"name":31,"count":25},"Chronic Obstructive Pulmonary Disease",[33,38,43,48,53],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06368804","Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis","2025-03-15","Antibiotic monotherapy treatment and follow-up",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT04356326","Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy","2026-02","Aspirin 150 mg",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT05157685","Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults","2027-11-21","Azithromycin Oral",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT07153367","Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)","2027-12-17","REKOVELLE",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07493785","Dexmedetomidine for Invasive Ventilation In the NEOnate","2032-08-01","Dexmedetomidine Injectable Solution",[59,60,61,62,63,64],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[66,96,114,141,163,186,204,226,253,291,313,338,365,393,411,441,459,477,504,522,550,568,586,604,622,646,672,696,721],{"intervention":57,"totalTrials":67,"cells":68},1,{"EARLY_PHASE1":69,"PHASE1":72,"PHASE2":74,"PHASE3":76,"PHASE4":92,"NA":94},{"trials":70,"activeCount":71},[],0,{"trials":73,"activeCount":71},[],{"trials":75,"activeCount":71},[],{"trials":77,"activeCount":67,"soonestReadout":56},[78],{"nctId":54,"briefTitle":55,"status":79,"phases":80,"primaryCompletion":56,"completion":81,"start":82,"enrollment":83,"conditions":84,"interventions":90},"NOT_YET_RECRUITING",[61,62],"2034-08-01","2026-06-01",246,[85,86,87,88,89],"Invasive Ventilation","Infant Pain","Infant Discomfort","Infant Neurodevelopment","Neonatal Respiratory Failure",[57,91],"Glucose 5% Injectable Solution",{"trials":93,"activeCount":71},[],{"trials":95,"activeCount":71},[],{"intervention":91,"totalTrials":67,"cells":97},{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":110,"NA":112},{"trials":99,"activeCount":71},[],{"trials":101,"activeCount":71},[],{"trials":103,"activeCount":71},[],{"trials":105,"activeCount":67,"soonestReadout":56},[106],{"nctId":54,"briefTitle":55,"status":79,"phases":107,"primaryCompletion":56,"completion":81,"start":82,"enrollment":83,"conditions":108,"interventions":109},[61,62],[85,86,87,88,89],[57,91],{"trials":111,"activeCount":71},[],{"trials":113,"activeCount":71},[],{"intervention":42,"totalTrials":67,"cells":115},{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":137,"NA":139},{"trials":117,"activeCount":71},[],{"trials":119,"activeCount":71},[],{"trials":121,"activeCount":71},[],{"trials":123,"activeCount":67,"soonestReadout":41},[124],{"nctId":39,"briefTitle":40,"status":125,"phases":126,"primaryCompletion":41,"completion":127,"start":128,"enrollment":129,"conditions":130,"interventions":136},"RECRUITING",[62],"2030-02","2021-02-15",500,[131,27,132,133,134,135],"Chronic Hypertension Complicating Pregnancy","Intrauterine Growth Restriction","Aspirin","Perinatal Death","Placental Abruption",[42],{"trials":138,"activeCount":71},[],{"trials":140,"activeCount":71},[],{"intervention":47,"totalTrials":67,"cells":142},{"EARLY_PHASE1":143,"PHASE1":145,"PHASE2":147,"PHASE3":149,"PHASE4":159,"NA":161},{"trials":144,"activeCount":71},[],{"trials":146,"activeCount":71},[],{"trials":148,"activeCount":71},[],{"trials":150,"activeCount":67,"soonestReadout":46},[151],{"nctId":44,"briefTitle":45,"status":125,"phases":152,"primaryCompletion":46,"completion":46,"start":153,"enrollment":154,"conditions":155,"interventions":158},[62],"2022-11-21",230,[156,157],"Sinusitis, Chronic","Sinus Infection Chronic",[47],{"trials":160,"activeCount":71},[],{"trials":162,"activeCount":71},[],{"intervention":37,"totalTrials":67,"cells":164},{"EARLY_PHASE1":165,"PHASE1":167,"PHASE2":169,"PHASE3":180,"PHASE4":182,"NA":184},{"trials":166,"activeCount":71},[],{"trials":168,"activeCount":71},[],{"trials":170,"activeCount":67,"soonestReadout":36},[171],{"nctId":34,"briefTitle":35,"status":125,"phases":172,"primaryCompletion":36,"completion":173,"start":174,"enrollment":175,"conditions":176,"interventions":178},[61],"2028-09-15","2024-09-15",196,[177],"Bronchiectasis",[37,179],"Antibiotic bitherapy treatment and follow-up",{"trials":181,"activeCount":71},[],{"trials":183,"activeCount":71},[],{"trials":185,"activeCount":71},[],{"intervention":179,"totalTrials":67,"cells":187},{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":198,"PHASE4":200,"NA":202},{"trials":189,"activeCount":71},[],{"trials":191,"activeCount":71},[],{"trials":193,"activeCount":67,"soonestReadout":36},[194],{"nctId":34,"briefTitle":35,"status":125,"phases":195,"primaryCompletion":36,"completion":173,"start":174,"enrollment":175,"conditions":196,"interventions":197},[61],[177],[37,179],{"trials":199,"activeCount":71},[],{"trials":201,"activeCount":71},[],{"trials":203,"activeCount":71},[],{"intervention":52,"totalTrials":67,"cells":205},{"EARLY_PHASE1":206,"PHASE1":208,"PHASE2":210,"PHASE3":220,"PHASE4":222,"NA":224},{"trials":207,"activeCount":71},[],{"trials":209,"activeCount":71},[],{"trials":211,"activeCount":67,"soonestReadout":51},[212],{"nctId":49,"briefTitle":50,"status":125,"phases":213,"primaryCompletion":51,"completion":214,"start":215,"enrollment":216,"conditions":217,"interventions":219},[61],"2028-03-17","2025-12-17",80,[20,218],"Insemination",[52],{"trials":221,"activeCount":71},[],{"trials":223,"activeCount":71},[],{"trials":225,"activeCount":71},[],{"intervention":227,"totalTrials":67,"cells":228},"ranibizumab",{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":237,"NA":251},{"trials":230,"activeCount":71},[],{"trials":232,"activeCount":71},[],{"trials":234,"activeCount":71},[],{"trials":236,"activeCount":71},[],{"trials":238,"activeCount":71},[239],{"nctId":240,"briefTitle":241,"status":242,"phases":243,"primaryCompletion":244,"completion":245,"start":246,"enrollment":247,"conditions":248,"interventions":250},"NCT01448018","Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion","COMPLETED",[63],"2013-06","2013-12","2010-01",45,[249],"Central Retinal Vein Occlusion",[227],{"trials":252,"activeCount":71},[],{"intervention":254,"totalTrials":255,"cells":256},"atropine+ propofol",2,{"EARLY_PHASE1":257,"PHASE1":259,"PHASE2":261,"PHASE3":263,"PHASE4":287,"NA":289},{"trials":258,"activeCount":71},[],{"trials":260,"activeCount":71},[],{"trials":262,"activeCount":71},[],{"trials":264,"activeCount":71},[265,278],{"nctId":266,"briefTitle":267,"status":242,"phases":268,"primaryCompletion":269,"completion":270,"start":271,"enrollment":272,"conditions":273,"interventions":276},"NCT01490580","Premedication Trial for Tracheal Intubation of the NEOnate",[61,62],"2016-08","2020-04-15","2012-05",173,[274,275],"Premedication","Endotracheal Intubation",[254,277],"atropine + atracurium + sufentanil",{"nctId":279,"briefTitle":280,"status":242,"phases":281,"primaryCompletion":269,"completion":269,"start":282,"enrollment":283,"conditions":284,"interventions":286},"NCT02700893","Cerebral NIRS Profiles During Premedication for Neonatal Intubation",[61,62],"2016-03",28,[274,275,285],"Cerebral Hypoperfusion",[254,277],{"trials":288,"activeCount":71},[],{"trials":290,"activeCount":71},[],{"intervention":277,"totalTrials":255,"cells":292},{"EARLY_PHASE1":293,"PHASE1":295,"PHASE2":297,"PHASE3":299,"PHASE4":309,"NA":311},{"trials":294,"activeCount":71},[],{"trials":296,"activeCount":71},[],{"trials":298,"activeCount":71},[],{"trials":300,"activeCount":71},[301,305],{"nctId":266,"briefTitle":267,"status":242,"phases":302,"primaryCompletion":269,"completion":270,"start":271,"enrollment":272,"conditions":303,"interventions":304},[61,62],[274,275],[254,277],{"nctId":279,"briefTitle":280,"status":242,"phases":306,"primaryCompletion":269,"completion":269,"start":282,"enrollment":283,"conditions":307,"interventions":308},[61,62],[274,275,285],[254,277],{"trials":310,"activeCount":71},[],{"trials":312,"activeCount":71},[],{"intervention":314,"totalTrials":67,"cells":315},"Estrogens",{"EARLY_PHASE1":316,"PHASE1":318,"PHASE2":320,"PHASE3":322,"PHASE4":334,"NA":336},{"trials":317,"activeCount":71},[],{"trials":319,"activeCount":71},[],{"trials":321,"activeCount":71},[],{"trials":323,"activeCount":71},[324],{"nctId":325,"briefTitle":326,"status":242,"phases":327,"primaryCompletion":328,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":333},"NCT02884245","Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa",[62],"2022-07-01","2023-01-04","2016-11-04",334,[20],[314],{"trials":335,"activeCount":71},[],{"trials":337,"activeCount":71},[],{"intervention":339,"totalTrials":67,"cells":340},"Aflibercept",{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":347,"PHASE4":361,"NA":363},{"trials":342,"activeCount":71},[],{"trials":344,"activeCount":71},[],{"trials":346,"activeCount":71},[],{"trials":348,"activeCount":71},[349],{"nctId":350,"briefTitle":351,"status":242,"phases":352,"primaryCompletion":353,"completion":353,"start":245,"enrollment":354,"conditions":355,"interventions":360},"NCT02157077","Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration",[62],"2015-12",90,[29,356,357,358,359],"Wet Macular Degeneration","Retinal Degeneration","Retinal Diseases","Eye Diseases",[339],{"trials":362,"activeCount":71},[],{"trials":364,"activeCount":71},[],{"intervention":366,"totalTrials":67,"cells":367},"Budesonide Formoterol Drug Combination",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":389,"NA":391},{"trials":369,"activeCount":71},[],{"trials":371,"activeCount":71},[],{"trials":373,"activeCount":71},[],{"trials":375,"activeCount":71},[376],{"nctId":377,"briefTitle":378,"status":379,"phases":380,"primaryCompletion":381,"completion":382,"start":383,"enrollment":384,"conditions":385,"interventions":387},"NCT04705727","Budesonide\u002FFormoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation","TERMINATED",[62],"2021-09-23","2023-06-23","2021-08-23",102,[386],"Asthma in Children",[366,388],"nebulisation of terbutaline",{"trials":390,"activeCount":71},[],{"trials":392,"activeCount":71},[],{"intervention":388,"totalTrials":67,"cells":394},{"EARLY_PHASE1":395,"PHASE1":397,"PHASE2":399,"PHASE3":401,"PHASE4":407,"NA":409},{"trials":396,"activeCount":71},[],{"trials":398,"activeCount":71},[],{"trials":400,"activeCount":71},[],{"trials":402,"activeCount":71},[403],{"nctId":377,"briefTitle":378,"status":379,"phases":404,"primaryCompletion":381,"completion":382,"start":383,"enrollment":384,"conditions":405,"interventions":406},[62],[386],[366,388],{"trials":408,"activeCount":71},[],{"trials":410,"activeCount":71},[],{"intervention":412,"totalTrials":67,"cells":413},"Cisplatin",{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":420,"PHASE4":437,"NA":439},{"trials":415,"activeCount":71},[],{"trials":417,"activeCount":71},[],{"trials":419,"activeCount":71},[],{"trials":421,"activeCount":71},[422],{"nctId":423,"briefTitle":424,"status":379,"phases":425,"primaryCompletion":426,"completion":427,"start":245,"enrollment":428,"conditions":429,"interventions":434},"NCT02162537","Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases",[62],"2018-03","2019-01",95,[430,431,432,433],"Non-small Cell Lung Cancer Metastatic","Non-small Cell Lung Cancer","Adenocarcinoma of Lung Metastatic to Brain","Cerebral Metastases",[412,435,436],"Pemetrexed","Bevacizumab",{"trials":438,"activeCount":71},[],{"trials":440,"activeCount":71},[],{"intervention":435,"totalTrials":67,"cells":442},{"EARLY_PHASE1":443,"PHASE1":445,"PHASE2":447,"PHASE3":449,"PHASE4":455,"NA":457},{"trials":444,"activeCount":71},[],{"trials":446,"activeCount":71},[],{"trials":448,"activeCount":71},[],{"trials":450,"activeCount":71},[451],{"nctId":423,"briefTitle":424,"status":379,"phases":452,"primaryCompletion":426,"completion":427,"start":245,"enrollment":428,"conditions":453,"interventions":454},[62],[430,431,432,433],[412,435,436],{"trials":456,"activeCount":71},[],{"trials":458,"activeCount":71},[],{"intervention":436,"totalTrials":67,"cells":460},{"EARLY_PHASE1":461,"PHASE1":463,"PHASE2":465,"PHASE3":467,"PHASE4":473,"NA":475},{"trials":462,"activeCount":71},[],{"trials":464,"activeCount":71},[],{"trials":466,"activeCount":71},[],{"trials":468,"activeCount":71},[469],{"nctId":423,"briefTitle":424,"status":379,"phases":470,"primaryCompletion":426,"completion":427,"start":245,"enrollment":428,"conditions":471,"interventions":472},[62],[430,431,432,433],[412,435,436],{"trials":474,"activeCount":71},[],{"trials":476,"activeCount":71},[],{"intervention":478,"totalTrials":67,"cells":479},"DUOSTIM",{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":484,"PHASE3":486,"PHASE4":500,"NA":502},{"trials":481,"activeCount":71},[],{"trials":483,"activeCount":71},[],{"trials":485,"activeCount":71},[],{"trials":487,"activeCount":71},[488],{"nctId":489,"briefTitle":490,"status":242,"phases":491,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":496,"interventions":498},"NCT03803228","Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders",[62],"2021-03-03","2021-11-24","2018-09-03",88,[497],"Fertility Disorders",[478,499],"Conventional stimuli",{"trials":501,"activeCount":71},[],{"trials":503,"activeCount":71},[],{"intervention":499,"totalTrials":67,"cells":505},{"EARLY_PHASE1":506,"PHASE1":508,"PHASE2":510,"PHASE3":512,"PHASE4":518,"NA":520},{"trials":507,"activeCount":71},[],{"trials":509,"activeCount":71},[],{"trials":511,"activeCount":71},[],{"trials":513,"activeCount":71},[514],{"nctId":489,"briefTitle":490,"status":242,"phases":515,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":516,"interventions":517},[62],[497],[478,499],{"trials":519,"activeCount":71},[],{"trials":521,"activeCount":71},[],{"intervention":523,"totalTrials":67,"cells":524},"Desogestrel early follicular phase",{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":546,"NA":548},{"trials":526,"activeCount":71},[],{"trials":528,"activeCount":71},[],{"trials":530,"activeCount":71},[],{"trials":532,"activeCount":71},[533],{"nctId":534,"briefTitle":535,"status":242,"phases":536,"primaryCompletion":537,"completion":537,"start":538,"enrollment":539,"conditions":540,"interventions":541},"NCT03895099","New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors",[62],"2023-10-30","2020-09-04",110,[20],[523,542,543,544,545],"Desogestrel medium follicular phase","Desogestrel ovulatory phase","Desogestrel late follicular phase","Desogestrel luteal phase",{"trials":547,"activeCount":71},[],{"trials":549,"activeCount":71},[],{"intervention":542,"totalTrials":67,"cells":551},{"EARLY_PHASE1":552,"PHASE1":554,"PHASE2":556,"PHASE3":558,"PHASE4":564,"NA":566},{"trials":553,"activeCount":71},[],{"trials":555,"activeCount":71},[],{"trials":557,"activeCount":71},[],{"trials":559,"activeCount":71},[560],{"nctId":534,"briefTitle":535,"status":242,"phases":561,"primaryCompletion":537,"completion":537,"start":538,"enrollment":539,"conditions":562,"interventions":563},[62],[20],[523,542,543,544,545],{"trials":565,"activeCount":71},[],{"trials":567,"activeCount":71},[],{"intervention":543,"totalTrials":67,"cells":569},{"EARLY_PHASE1":570,"PHASE1":572,"PHASE2":574,"PHASE3":576,"PHASE4":582,"NA":584},{"trials":571,"activeCount":71},[],{"trials":573,"activeCount":71},[],{"trials":575,"activeCount":71},[],{"trials":577,"activeCount":71},[578],{"nctId":534,"briefTitle":535,"status":242,"phases":579,"primaryCompletion":537,"completion":537,"start":538,"enrollment":539,"conditions":580,"interventions":581},[62],[20],[523,542,543,544,545],{"trials":583,"activeCount":71},[],{"trials":585,"activeCount":71},[],{"intervention":544,"totalTrials":67,"cells":587},{"EARLY_PHASE1":588,"PHASE1":590,"PHASE2":592,"PHASE3":594,"PHASE4":600,"NA":602},{"trials":589,"activeCount":71},[],{"trials":591,"activeCount":71},[],{"trials":593,"activeCount":71},[],{"trials":595,"activeCount":71},[596],{"nctId":534,"briefTitle":535,"status":242,"phases":597,"primaryCompletion":537,"completion":537,"start":538,"enrollment":539,"conditions":598,"interventions":599},[62],[20],[523,542,543,544,545],{"trials":601,"activeCount":71},[],{"trials":603,"activeCount":71},[],{"intervention":545,"totalTrials":67,"cells":605},{"EARLY_PHASE1":606,"PHASE1":608,"PHASE2":610,"PHASE3":612,"PHASE4":618,"NA":620},{"trials":607,"activeCount":71},[],{"trials":609,"activeCount":71},[],{"trials":611,"activeCount":71},[],{"trials":613,"activeCount":71},[614],{"nctId":534,"briefTitle":535,"status":242,"phases":615,"primaryCompletion":537,"completion":537,"start":538,"enrollment":539,"conditions":616,"interventions":617},[62],[20],[523,542,543,544,545],{"trials":619,"activeCount":71},[],{"trials":621,"activeCount":71},[],{"intervention":623,"totalTrials":67,"cells":624},"bone marrow transplant",{"EARLY_PHASE1":625,"PHASE1":627,"PHASE2":629,"PHASE3":640,"PHASE4":642,"NA":644},{"trials":626,"activeCount":71},[],{"trials":628,"activeCount":71},[],{"trials":630,"activeCount":71},[631],{"nctId":632,"briefTitle":633,"status":242,"phases":634,"primaryCompletion":635,"completion":635,"start":636,"enrollment":637,"conditions":638,"interventions":639},"NCT03240731","HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease",[61],"2024-04-08","2017-08-10",25,[15],[623],{"trials":641,"activeCount":71},[],{"trials":643,"activeCount":71},[],{"trials":645,"activeCount":71},[],{"intervention":647,"totalTrials":67,"cells":648},"Blood Test",{"EARLY_PHASE1":649,"PHASE1":651,"PHASE2":653,"PHASE3":655,"PHASE4":657,"NA":659},{"trials":650,"activeCount":71},[],{"trials":652,"activeCount":71},[],{"trials":654,"activeCount":71},[],{"trials":656,"activeCount":71},[],{"trials":658,"activeCount":71},[],{"trials":660,"activeCount":71},[661],{"nctId":662,"briefTitle":663,"status":242,"phases":664,"primaryCompletion":665,"completion":666,"start":667,"enrollment":668,"conditions":669,"interventions":671},"NCT04417777","Genetic Study of the Dilatations of the Idiopathic Bronchi in French Polynesia",[],"2022-03-08","2024-08-08","2022-02-10",20,[670],"Idiopathic Bronchiectasis",[647],{"intervention":673,"totalTrials":67,"cells":674},"Biological test",{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":679,"PHASE3":681,"PHASE4":683,"NA":685},{"trials":676,"activeCount":71},[],{"trials":678,"activeCount":71},[],{"trials":680,"activeCount":71},[],{"trials":682,"activeCount":71},[],{"trials":684,"activeCount":71},[],{"trials":686,"activeCount":71},[687],{"nctId":688,"briefTitle":689,"status":379,"phases":690,"primaryCompletion":691,"completion":691,"start":692,"enrollment":129,"conditions":693,"interventions":695},"NCT04363385","Collection of Biological Samples With Clinical Characterization of Covid-19 Patients",[64],"2023-05-31","2020-05-31",[694],"Covid-19",[673],{"intervention":697,"totalTrials":67,"cells":698},"Sampling",{"EARLY_PHASE1":699,"PHASE1":701,"PHASE2":703,"PHASE3":705,"PHASE4":707,"NA":709},{"trials":700,"activeCount":71},[],{"trials":702,"activeCount":71},[],{"trials":704,"activeCount":71},[],{"trials":706,"activeCount":71},[],{"trials":708,"activeCount":71},[],{"trials":710,"activeCount":71},[711],{"nctId":712,"briefTitle":713,"status":714,"phases":715,"primaryCompletion":716,"completion":716,"start":717,"enrollment":718,"conditions":719,"interventions":720},"NCT03614481","Clinical and Genetic Analyzes of Age-related Macular Degeneration","UNKNOWN",[],"2024-11","2005-11",6000,[29],[697],{"intervention":722,"totalTrials":67,"cells":723},"Optive",{"EARLY_PHASE1":724,"PHASE1":726,"PHASE2":728,"PHASE3":730,"PHASE4":732,"NA":734},{"trials":725,"activeCount":71},[],{"trials":727,"activeCount":71},[],{"trials":729,"activeCount":71},[],{"trials":731,"activeCount":71},[],{"trials":733,"activeCount":71},[],{"trials":735,"activeCount":71},[736],{"nctId":737,"briefTitle":738,"status":242,"phases":739,"primaryCompletion":740,"completion":741,"start":742,"enrollment":247,"conditions":743,"interventions":747},"NCT02806830","Ocular Discomfort Assessment After Intravitreal Injections",[64],"2017-01","2017-07-01","2016-04",[29,744,745,746],"Diabetic Retinopathy","Retinal Artery Occlusion","Myopia, Degenerative",[722]]